Dermatology Development Pharma Companies 
pharmaphorum
JULY 5, 2021
Spanish drugmaker Almirall has launched another search for early-stage research projects that it can partner in dermatology, its core area of expertise. ” Earlier iterations have focused on immuno-inflammatory skin conditions, novel targets for skin health and pharmacological validated research models in skin diseases.
pharmaphorum
FEBRUARY 1, 2021
It’s well recognised that people with psoriasis can develop depression or anxiety, particularly in moderate or severe cases where a sizeable part of the body can have skin lesions. It’s not the first time that Almirall has partnered with a digital health specialist to develop tools that complement its drug therapies for psoriasis.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 18, 2022
Two Spanish pharma companies are joining forces to identify new oral treatments for immune-inflammatory skin diseases with high unmet medical needs. It’s an amazing opportunity to put their knowledge and experience in dermatology, together with our expertise in molecular glues to accelerate drug discovery to treat skin diseases.
pharmaphorum
JULY 8, 2022
The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. However, few of the current digital solutions are medical-grade devices and more work is needed to develop tools that are fit for purpose. New sensor technology revolutionising data collection.
XTalks
NOVEMBER 2, 2023
The biosimilar to Johnson & Johnson’s Stelara is approved for use by adults for the listed indications, as well as pediatric patients six years of age and older for the dermatologic indications (plaque psoriasis and psoriatic arthritis). billion in sales, accounting for ten percent of Johnson & Johnson’s revenue.
pharmaphorum
APRIL 8, 2022
People with psoriasis who used an app developed by digital health company Happify reported reduced anxiety and improvements in mental wellbeing in a real-world study involving more than two hundred subjects.
The Pharma Data
DECEMBER 17, 2020
Kurtz brings more than 26 years of experience in global manufacturing, engineering, supply chain, CMC development and program management for drugs and devices at various stages of development. Cadavid will be responsible for the strategy, direction and execution of the company’s clinical development programs.
Expert insights. Personalized for you.
59 
Let's personalize your content